Why coverage outranks speed when Wentzville adults pick care
Fast sounds like everything when you have been down a long time, yet it ranked low; why coverage won, and why distance came in second.
When you have been depressed for a long time, "fast" sounds like the most important word in the world. So it may be surprising that when people rank provider traits for newer depression care, speed lands far down the list. Coverage sits at the top, by a wide margin.
This explainer looks at why, drawing on 443 adults who answered our ten-state Midwest poll this summer, and what the ordering means for someone in Wentzville. Pollfish has validated the figures.
What people chose
Our poll let each respondent name two traits they would want in a ketamine or esketamine provider. Insurance led at 85 percent and a nearby site followed at 43 percent. FDA approval collected 27 percent, quick relief 24 percent, and trailing them were privacy, which 11 percent chose, and veteran-focused care, the choice of 10 percent.
Coverage, in other words, beat speed by better than three to one.
Reason one: speed without coverage is not speed for most people
A fast option you cannot afford is not actually fast. It is a wall. For many households, paying the full cost of a series of treatments is out of reach, so a quicker start at a self-pay clinic is not a real choice.
The poll shows how strongly that concern runs: 65 percent of respondents put coverage in the big or deciding tier, while a mere 14 percent said coverage would play no role.
Reason two: people are willing to wait if coverage is at the end
We asked a direct tradeoff question. Would you rather take a route that is covered by insurance but involves more hoops, or pay yourself and keep it simpler? Just over half chose coverage with hoops. Nearly a quarter chose paying themselves. The rest, about a quarter, were not sure.
Many people, it seems, have made peace with some delay in exchange for coverage.
Reason three: "fast" is a promise nobody can make
Newer depression treatments are sometimes marketed with an emphasis on speed. It is true that esketamine works differently from traditional antidepressants. But no one can promise a result for any particular person, and no responsible provider should. Responses vary widely, and your own clinician is the one to talk frankly about expectations.
Many respondents may have sensed that. When a factor cannot be promised, it makes sense to prioritize the ones that can: whether you can pay, and whether you can get there.
Reason four: approval matters, but people already count on it
FDA approval edged speed by only three points in the ranking, but a separate question tells a fuller story. Judged alone, approval turned out to matter a lot, or to settle things, for 59 percent of respondents.
So why did it not rank higher when people had only two picks? One reasonable explanation is that many people assume a covered treatment is an approved one, so choosing coverage feels like it covers both. That assumption is often reasonable for esketamine, and not for everything labeled ketamine. More on that below.
What esketamine actually involves
Spravato, a nasal form of esketamine, was approved by the FDA for adults who did not get enough relief from earlier antidepressants. Only certified clinics can administer it, with a couple of hours of observation per dose and a ride home afterward. Wentzville readers can find a plain rundown of esketamine costs and coverage from Brain Recovery Centers.
IV infusions and home-use ketamine programs rely on off-label use for depression, a different product with a different regulatory footing, and it is less often covered. Some self-pay clinics emphasize speed because they do not have to wait on insurance. That is a real tradeoff, but it is not the same treatment.
Why distance ranked second
Wentzville sits where the St. Louis metro runs out to the west. For many residents, the nearest certified site may be a drive east along I-70, toward O'Fallon, St. Peters, or beyond. Because each session requires a ride home, that drive is doubled for whoever takes you, and repeated across several visits early in treatment.
That is why 43 percent put proximity in their top two. A covered site that is hard to reach can end up being almost as limiting as one that is not covered.
Putting the ranking to work
If you are in Wentzville and considering this kind of care, the survey's ordering makes a sensible plan:
- Coverage first. Call the plan first. Ask about esketamine coverage, any prior authorization, and the closest in-network certified sites.
- Distance second. Map the covered sites. Think through the driving for someone else, not just you. If you are on MO HealthNet, ask whether your plan covers rides to appointments.
- Approval third. Confirm what you would be receiving: FDA-approved esketamine, or off-label ketamine.
- Speed last. Ask how long it usually takes to start, but do not let it override the first three.
Start with the person you trust
The survey found that most people would begin with a familiar face. More than half, 56 percent, would begin with a primary doctor, and 74 percent would be moved by that doctor's recommendation. Tell your doctor that coverage matters to you. They can help document your history for prior authorization and point you to a site that fits.
Whether esketamine is a good option for you is a medical decision. Your doctor may suggest another step first. Consider this background rather than medical advice; results are never assured.
If waiting feels impossible because you are in crisis, please do not wait. A call or text to 988 gets a Suicide and Crisis Lifeline counselor right away, free and at any hour.
Methodology
For Wentzville readers: the source is Pollfish survey 395586438, fielded with Pollfish panelists through June 23, 2026, producing 443 completes from working-age people in Missouri, Oklahoma, Iowa, Indiana, Kansas, Wisconsin, Ohio, Minnesota, Illinois and Nebraska. The provider question took two picks per person. Its shares cover all 443 and are final. The publisher commissioned and paid for it.